Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s displayed release/version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:25:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Italy location entry updated from Padua, Veneto, Italy, 35128 to Padova, Veneto, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T20:53:44.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Naples, Campania, Italy, 80131 was added and Napoli, Campania, Italy, 80131 was removed from the location list. The update aligns site naming with English-language conventions and improves site identification for users.
    Difference
    0.0%
    Check dated 2026-03-26T11:27:06.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:16:51.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page now states that the trial was terminated globally (excluding US and Greater China) with results posted, and it adds details showing 74 study locations.
    Difference
    2%
    Check dated 2026-03-11T23:49:45.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.